Article ; Online: Reply: Navigating the Role of Ticagrelor in Elective Complex PCI: Time to Rule Out or Reassess?
JACC. Cardiovascular interventions
2024 Volume 17, Issue 8, Page(s) 1070
MeSH term(s) | Humans ; Ticagrelor/therapeutic use ; Ticagrelor/adverse effects ; Percutaneous Coronary Intervention/adverse effects ; Platelet Aggregation Inhibitors/therapeutic use ; Platelet Aggregation Inhibitors/adverse effects ; Treatment Outcome ; Clinical Decision-Making ; Risk Factors ; Purinergic P2Y Receptor Antagonists/therapeutic use ; Purinergic P2Y Receptor Antagonists/adverse effects ; Risk Assessment ; Patient Selection ; Coronary Artery Disease/therapy ; Coronary Artery Disease/diagnostic imaging ; Coronary Artery Disease/mortality ; Hemorrhage/chemically induced |
---|---|
Chemical Substances | Ticagrelor (GLH0314RVC) ; Platelet Aggregation Inhibitors ; Purinergic P2Y Receptor Antagonists |
Language | English |
Publishing date | 2024-01-11 |
Publishing country | United States |
Document type | Letter |
ZDB-ID | 2452157-7 |
ISSN | 1876-7605 ; 1936-8798 |
ISSN (online) | 1876-7605 |
ISSN | 1936-8798 |
DOI | 10.1016/j.jcin.2024.03.018 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 6669: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.